Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.253ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.253EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.253EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.253ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.253ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.305EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.305ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.305ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.305EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.305EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.305ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.305ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AA.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AA.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AA.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AA.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AA.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.241EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.241EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.241ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.241ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.241EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.241EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.241ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.241ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.43.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.43.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.43.2 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.43.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.43.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used